These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36452054)

  • 1. Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice.
    Pan X; Yue L; Ban J; Ren L; Chen S
    J Inflamm Res; 2022; 15():6409-6425. PubMed ID: 36452054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice.
    Zhu R; Chen S
    Front Endocrinol (Lausanne); 2023; 14():1095432. PubMed ID: 37025414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice.
    Yue L; Chen S; Ren Q; Niu S; Pan X; Chen X; Li Z; Chen X
    Front Endocrinol (Lausanne); 2022; 13():995007. PubMed ID: 36419767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Silibinin on Protein Expression Profile in White Adipose Tissue of Obese Mice.
    Wang F; Chen S; Ren L; Wang Y; Li Z; Song T; Zhang H; Yang Q
    Front Pharmacol; 2020; 11():55. PubMed ID: 32184719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice.
    Chen X; Chen S; Li Z; Zhu R; Jia Z; Ban J; Zhen R; Chen X; Pan X; Ren Q; Yue L; Niu S
    Front Pharmacol; 2023; 14():975830. PubMed ID: 37007007
    [No Abstract]   [Full Text] [Related]  

  • 6. Proteomics study on the effect of silybin on cardiomyopathy in obese mice.
    Wang F; Li Z; Song T; Jia Y; Qi L; Ren L; Chen S
    Sci Rep; 2021 Mar; 11(1):7136. PubMed ID: 33785854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated proteomics-based analysis of the effects of semaglutide on hippocampi of high-fat diet-induced-obese mice.
    Chen X; Ma L; Gan K; Pan X; Chen S
    Diabetol Metab Syndr; 2023 Mar; 15(1):63. PubMed ID: 36998046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism.
    Ren Q; Chen S; Chen X; Niu S; Yue L; Pan X; Li Z; Chen X
    Drug Des Devel Ther; 2022; 16():3723-3735. PubMed ID: 36304787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaglutide (GLP-1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice.
    Martins FF; Marinho TS; Cardoso LEM; Barbosa-da-Silva S; Souza-Mello V; Aguila MB; Mandarim-de-Lacerda CA
    Cell Biochem Funct; 2022 Dec; 40(8):903-913. PubMed ID: 36169111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-fat diet and empagliflozin on cardiac proteins in mice.
    Pan X; Chen S; Chen X; Ren Q; Yue L; Niu S; Li Z; Zhu R; Chen X; Jia Z; Zhen R; Ban J
    Nutr Metab (Lond); 2022 Oct; 19(1):69. PubMed ID: 36242090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model.
    Niu S; Chen S; Chen X; Ren Q; Yue L; Pan X; Zhao H; Li Z; Chen X
    Front Endocrinol (Lausanne); 2022; 13():1046130. PubMed ID: 36568109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice.
    Chen X; Chen S; Ren Q; Niu S; Pan X; Yue L; Li Z; Zhu R; Jia Z; Chen X; Zhen R; Ban J
    Drug Des Devel Ther; 2022; 16():3893-3913. PubMed ID: 36388084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics.
    Pan X; Zhang X; Ban J; Yue L; Ren L; Chen S
    Diabetes Metab Syndr Obes; 2023; 16():873-882. PubMed ID: 37012931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis reveals proteins and pathways associated with declined testosterone production in male obese mice after chronic high-altitude exposure.
    Wang S; Wei Y; Hu C; Liu F
    Front Endocrinol (Lausanne); 2022; 13():1046901. PubMed ID: 36531490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptome reveals effects of semaglutide on non-cardiomyocytes of obese mice.
    Pan X; Chen X; Ren Q; Yue L; Niu S; Li Z; Zhu R; Chen X; Jia Z; Zhen R; Ban J; Chen S
    Biochem Biophys Res Commun; 2022 Sep; 622():22-29. PubMed ID: 35843090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obese mice weight loss role on nonalcoholic fatty liver disease and endoplasmic reticulum stress treated by a GLP-1 receptor agonist.
    Pontes-da-Silva RM; de Souza Marinho T; de Macedo Cardoso LE; Mandarim-de-Lacerda CA; Aguila MB
    Int J Obes (Lond); 2022 Jan; 46(1):21-29. PubMed ID: 34465857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice.
    Reis-Barbosa PH; Marcondes-de-Castro IA; Marinho TS; Aguila MB; Mandarim-de-Lacerda CA
    Clin Res Hepatol Gastroenterol; 2022; 46(6):101922. PubMed ID: 35427802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaglutide attenuates excessive exercise-induced myocardial injury through inhibiting oxidative stress and inflammation in rats.
    Li Q; Tuo X; Li B; Deng Z; Qiu Y; Xie H
    Life Sci; 2020 Jun; 250():117531. PubMed ID: 32151691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilosocereus gounellei (Cactaceae) stem extract decreases insulin resistance, inflammation, oxidative stress, and cardio-metabolic risk in diet-induced obese mice.
    de Oliveira AM; de Freitas AFS; Costa MDS; Torres MKDS; Castro YAA; Almeida AMR; Paiva PMG; Carvalho BM; Napoleão TH
    J Ethnopharmacol; 2021 Jan; 265():113327. PubMed ID: 32871234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice.
    Wang Y; Zhao H; Yang L; Zhang H; Yu X; Fei W; Zhen Y; Gao Z; Chen S; Ren L
    Bioengineered; 2022 Mar; 13(3):6750-6766. PubMed ID: 35246007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.